AAAAAA
Results:
1-15
|
Results: 15
Authors:
Mueck, AO
Seeger, H
Ludtke, R
Graser, T
Wallwiener, D
Citation: Ao. Mueck et al., Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest, MATURITAS, 38(3), 2001, pp. 305-313
Authors:
Hoffmann, H
Graser, T
Citation: H. Hoffmann et T. Graser, DIENOGEST - A clinical study update on dienogest-containing products for hormone replacement therapy - Preface, DRUGS TODAY, 37, 2001, pp. 1-1
Authors:
Oettel, M
Graser, T
Hoffmann, H
Citation: M. Oettel et al., Why dienogest as a progestogenic component of postmenopausal nonandrogenichormone replacement therapy?, DRUGS TODAY, 37, 2001, pp. 3-15
Authors:
Graser, T
Hoffmann, H
Zimmermann, H
Oettel, M
Citation: T. Graser et al., Lafamme (R): A new oral preparation for continuous combined hormone replacement therapy in postmenopausal women, DRUGS TODAY, 37, 2001, pp. 17-27
Authors:
Hoffmann, H
Felsch, B
Muller, A
Graser, T
Citation: H. Hoffmann et al., Safety profile of a fixed formulation containing 2 mg estradiol valerate and 2 mg dienogest (Lafamme (R)) for continuous combined hormone replacementtreatment in postmenopausal women, DRUGS TODAY, 37, 2001, pp. 29-37
Authors:
Graser, T
Muller, A
Druckman, R
Oettel, M
Citation: T. Graser et al., Effects of a combination of 2 mg estradiol valerate and 3 mg dienogest on coagulation, lipid profile, and glucose metabolism in postmenopausal women, DRUGS TODAY, 37, 2001, pp. 87-99
Authors:
Golbs, S
Zimmermann, H
Nikolov, R
Rudolph, I
Graser, T
Schroder, J
Citation: S. Golbs et al., The pharmacological and clinical profile of Klimonorm (R). An overview, DRUGS TODAY, 37, 2001, pp. 9-18
Authors:
Linzmayer, L
Semlitsch, HV
Saletu, B
Bock, G
Saletu-Zyhlarz, G
Zoghlami, A
Gruber, D
Metka, M
Huber, J
Oettel, M
Graser, T
Grunberger, J
Citation: L. Linzmayer et al., Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients, ARZNEI-FOR, 51(3), 2001, pp. 238-245
Authors:
Klinger, G
Graser, T
Mellinger, U
Moore, C
Vogelsang, H
Groh, A
Latterman, C
Klinger, G
Citation: G. Klinger et al., A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system, GYNECOL END, 14(1), 2000, pp. 15-24
Authors:
Graser, T
Muller, A
Mellinger, U
Muck, AO
Lippert, TH
Oettel, M
Citation: T. Graser et al., Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study, MATURITAS, 35(3), 2000, pp. 253-261
Authors:
Seeger, H
Ludtke, R
Graser, T
Wallwiener, D
Mueck, AO
Citation: H. Seeger et al., Effect of oral contraceptives on the urinary excretion of biochemical markers indicating vasoactive action, J CLIN PH T, 25(3), 2000, pp. 221-226
Authors:
Moore, C
Carol, W
Graser, T
Mellinger, U
Walter, F
Citation: C. Moore et al., Influence of dienogest on ovulation in young fertile women, CLIN DRUG I, 18(4), 1999, pp. 271-278
Authors:
Oettel, M
Graser, T
Hoffmann, H
Moore, C
Zimmermann, H
Zimmermann, T
Citation: M. Oettel et al., The preclinical and clinical profile of dienogest. A short overview, DRUGS TODAY, 35, 1999, pp. 3-12
Authors:
Hoffmann, H
Moore, C
Kovacs, L
Teichmann, AT
Klinger, G
Graser, T
Oettel, M
Citation: H. Hoffmann et al., Alternatives for the replacement of ethinylestradiol by natural 17 beta-estradiol in dienogest-containing oral contraceptives, DRUGS TODAY, 35, 1999, pp. 105-113
Authors:
Graser, T
Koytchev, R
Romer, T
Georgiev, DB
Muller, A
Hoffmann, H
Oettel, M
Citation: T. Graser et al., Dienogest as a progestin for hormone replacement therapy, DRUGS TODAY, 35, 1999, pp. 115-126
Risultati:
1-15
|